Amazentis Sa

Vandria Sa

Dfb Technology Holdings, LLC

Dfb Pharmaceuticals, Inc.

Smith + Nephew

Modex Therapeutiques

Christopher Rinsch

Penelope Andreux

William Blanco-Bose

Johan Auwerx

Bernard Schneider

Laurent Mouchiroud

Carmen Sandi

Eija Pirinen

David Genoux

Thomas Hunziker

Eric Rolland

Richardus Houtkooper

Beatrice Mis

Charles Thomas

Eileen Mary Seward

Jonathan Mark Sutton

Florent Beaufils

Anurag Singh

Dongryeol Ryu

Peter C Sennhenn

Thomas Christian Fessard

Jamie D Knight

Ian Linney

Said Oumouch

Davide D'Amico

Rune A Ringom

Wolfgang Skranc

Beatrice Chevallay

Rune Ringom

Philippe V Dupraz

Nicole Deglon

Patrick Aebischer

Roland Müller

Etienne Regulier

Eric Holland

Philippe Victor Leon Dupraz

Roland Mueller

Philippe Victor Dupraz

Pénélope Andreux

Disclosed are compounds, compositions, and methods useful for treating neuronal and mitochondrial diseases.

Urolithin derivatives and methods of use thereof

Provided are compositions comprising compounds or precursors to compounds which may be used for a variety of therapeutic applications including, for example, treating and/or preventing a disease or disorder related to reduced or inadequate mitochondrial activity, including aging or stress, diabetes, obesity, and neurodegenerative diseases. The compounds relate generally to urolithins and precursors thereof, including but not limited to ellagitannins and urolithin A. In certain embodiments the compositions are presented in or as food products or nutritional supplements. These same compounds and compositions can also be used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase or maintain muscle mass, manage body weight, improve or maintain mental performance (including memory), improve or maintain muscle performance, improve or maintain mood, and manage stress.

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

The invention provides compositions comprising a source of protein and a urolithin. The invention also provides uses and methods associated with, or making use of the compositions, such as a medicament, dietary supplement, functional food or medical food and in the treatment and/or prophylaxis of a muscle-related pathological condition. The invention also provides kits comprising urolithin and protein.

Compositions comprising an urolithin compound

A composition comprising: wherein:A, B, C and D are each independently selected from H and OH;W, X and Y are each independently selected from H and OH; andZ is selected from H and OH. The compositions are useful as medicaments, for example for treating muscle-related pathological conditions, neurodegenerative diseases, and/or mitochondrial diseases and as dietary supplements, functional foods and beverages, and specialised nutrition or medical foods.

Compositions comprising nicotinamide riboside and a urolithin

Disclosed are compounds for use in raising an immune response to an antigen and/or enhancing, modulating or augmenting an immune response to an antigen. Particularly the use of urolithins. The invention also relates to immune enhancers comprising urolithins, methods of using such immune enhancers and processes for the preparation of such immune enhancers. The invention also relates to the use of urolithins in methods for modulating stem cell function, for example, enhancing stem cell numbers, promoting stem cell regeneration and promoting stem cell differentiation.

Urolithins as immune response enhancers

The invention provides compounds of formula (I) or salts thereof: The compounds are effective pro-drugs for urolithins and they enable the ready delivery of urolithins to the site in the digestive tract where they can be absorbed into the body.

Prodrugs of urolithins and uses thereof

The invention provides a compound of formula (I)

Method for improving mitophagy in subjects

Disclosed are methods, compounds, and compositions useful for increasing autophagy and promoting longevity. The methods, compounds, and compositions relate to urolithins and urolithin precursors and use thereof. Certain urolithins are represented by Formula I, while certain urolithin precursors are represented by Formula IV. The urolithin may be urolithin A, urolithin B, urolithin C, or urolithin D. The urolithin precursor may be ellagic acid or an ellagitannin. The methods include in vivo, ex vivo, and in vitro uses of the compounds and compositions.

Enhancing autophagy or increasing longevity by administration of urolithins

Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

The invention provides compositions comprising a medium chain triglyceride and a urolithin. The invention also provides uses and methods associated with, or making use of the compositions, such as a medicament, dietary supplement, functional food or medical food and in the treatment and/or prophylaxis of a muscle-related pathological condition.

Compositions comprising urolithin compounds

Growing community of inventors

Morges, Switzerland

Christopher Rinsch